Page Comparison

Examining inequities in access to opioid agonist treatment (OAT) take-home doses (THD): A Canadian OAT guideline synthesis and systematic review

Created by Cayley Russell, Jenna Ashley, Farihah Ali, Nikki Bozinoff, Kim Corace, David Marsh, Christopher Mushquash, Jennifer Wyman, Maria Zhang, Shannon Lange

Daily supervised Opioid Agonist Treatment (OAT) medication has been identified as a barrier to treatment retention. Canadian OAT guidelines outline take-home dose (THD) criteria, yet, OAT prescribers use their clinical…